Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
RIVIERA
2 other identifiers
observational
600
1 country
1
Brief Summary
This study aims to evaluate the feasibility (acceptability) of a consultation dedicated to informing women about their risk of breast cancer and the screening methods recommended for them according to the recommendations in force during a routine consultation at a general practitioner, a gynecologist or a radiologist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 13, 2016
CompletedFirst Posted
Study publicly available on registry
December 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedDecember 20, 2016
December 1, 2016
6 months
December 13, 2016
December 15, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of women who agreed to measure their risk with personalized surveillance and screening recommendations during the consultation
up to 1 year
Study Arms (3)
General practitioner
gynecologist
radiologist
Interventions
information of women about their risk of breast cancer and the screening methods recommended for them
Eligibility Criteria
Women 40 to 74 years seen in consultation by their attending physician, gynecologist or radiologist
You may qualify if:
- Woman from 40 to 74 years old
- Understanding the French language
You may not qualify if:
- Women will not be eligible for study if they are in any of the following situations:
- Cancer active or in the course of treatment type surgery, chemotherapy, or radiotherapy, whether breast or other organ
- Recent diagnosis \<1 year of suspicious or cancerous lesions
- Psychiatric pathology not compatible with the study
- Poor understanding of the French language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gustave Roussy
Villejuif, Val de Marne, 94805, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2016
First Posted
December 20, 2016
Study Start
December 1, 2016
Primary Completion
June 1, 2017
Study Completion
June 1, 2018
Last Updated
December 20, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share